Lifemd, Inc. (LFMDP) Stock Price & Analysis
Lifemd, Inc. (LFMDP) rose 0.74% to USD 23.93 as of June 10, 2026 at 13:16 UTC, according to Nexqual real-time market data.
LFMDP last closed at USD 23.75; the session ranged USD 23.62–23.93 on volume of 1,418 shares. Market capitalization is —, with a 52-week range of USD 18.5–24.34 (NGM). Source: Nexqual, June 10, 2026 at 13:16 UTC.
Key Statistics (as of June 10, 2026 at 13:16 UTC)
| Price | USD 23.93 |
|---|---|
| Change | ▲ 0.74% (up) |
| Previous Close | USD 23.75 |
| Open | USD 23.92 |
| Day Range | USD 23.62 – 23.93 |
| 52-Week Range | USD 18.5 – 24.34 |
| Volume | 1,418 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (LFMDP)
Nexqual's technical model rates LFMDP "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 13:16 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.14 (neutral) |
| vs SMA50 | Above (USD 23.73) |
| MACD | 0.02 (positive) |
Analyst Ratings (LFMDP)
Wall Street analysts rate LFMDP "None", per Nexqual as of June 10, 2026 at 13:16 UTC.
| Consensus Rating | None |
|---|
Earnings (LFMDP)
| Revenue Estimate | $49.15M |
|---|
Source: Nexqual, June 10, 2026 at 13:16 UTC.
Financials & Fundamentals (LFMDP)
| Total Revenue | $193.33M |
|---|---|
| Revenue Growth (YoY) | -1.40% |
| Gross Margin | +86.81% |
| Operating Margin | -17.80% |
| Profit Margin | +2.93% |
| ROE | -238.45% |
| Debt / Equity | 41.05 |
| Current Ratio | 1.04 |
| Total Cash | $34.48M |
| Total Debt | $6.17M |
| Free Cash Flow | $-4.16M |
Source: Nexqual, June 10, 2026 at 13:16 UTC.
Financial Health Score (LFMDP)
Nexqual rates Lifemd, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 13:16 UTC.
| Growth | Weak — Revenue -9% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 87%, operating -18% |
| Balance Sheet | Solid — $34M cash vs $6M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -238%, ROA -13.4% |
Ownership (LFMDP)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Float | 40.08M |
Source: Nexqual, June 10, 2026 at 13:16 UTC.
Leadership (LFMDP)
Lifemd, Inc. is led by Justin Schreiber (age 42), Chairman & CEO, per Nexqual as of June 10, 2026 at 13:16 UTC.
| Chairman & CEO | Justin Schreiber (age 42) |
|---|---|
| Chief Operating Officer | Shayna Webb Dray (age 38) |
| Chief Financial Officer | Atul Kavthekar |
| Chief Technology Officer | Umesh Sripad |
| Chief Marketing Officer | Chris Pisano (age 50) |
Major Backers & Investors (LFMDP)
Notable institutional backers of Lifemd, Inc. include High Income Securities Fund, according to Nexqual as of June 10, 2026 at 13:16 UTC.
Active Investors
| Investor | Stake |
|---|---|
| High Income Securities Fund | 0.57% |
Source: Nexqual, June 10, 2026 at 13:16 UTC.
From Lifemd, Inc.'s Latest SEC 10-K Filing (filed 2026-03-10)
Key Strengths & Strategy (as disclosed to the SEC)
- Approximately 95% of our total revenue is derived from recurring subscriptions.   Our End-to-End Telehealth Platform   LifeMD has developed a proprietary, fully integrated telehealth and pharmacy platform designed to support diagnosis, treatment, prescription fulfillment, and ongoing care management within a unified ecosystem.
- Our human capital and know-how, proprietary technology platform, and unique product offerings represent meaningful strengths that we believe will enable us to maintain and grow our market-leading position in the U.S.    Our key competitive strengths include:     Discontinued Operations   On November 4, 2025, we sold our majority ownership interest in WorkSimpli to Lion Buyer, LLC.
- At the same time, the United States ("U.S.") continues to experience shortages in primary care key specialty areas.   Through our vertically integrated care model, we combine proprietary technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence ("AI")-enabled operational systems to deliver longitudinal care at scale.
- As of December 31, 2025, our network covered approximately 112 million lives, including approximately 30 million Medicare Fee-for-Service beneficiaries.
Partnerships
- We entered into a management services agreement with LifeMD PC pursuant to which we provide them with billing, scheduling and a wide range of other services, and they pay us for those services.
- Secondly, we have partnered with an AI-powered platform that optimizes prior authorization submissions and aims to improve approval rates for patients.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDZIP | Cadiz, Inc. - Depositary Shares | USD 22.5 | ▲ 0.22% |
| STRRP | Star Equity Holdings, Inc. - 10 | USD 9.7 | ▼ 0.31% |
| VIASP | Via Renewables, Inc. - 8.75% Se | USD 25.52 | ▲ 0.06% |
| ADAML | Adamas Trust, Inc. - 6.875% Ser | USD 24.18 | ▲ 0.33% |
| ADAMZ | Adamas Trust, Inc. - 7.000% Ser | USD 18.65 | ▲ 2.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:16 UTC. This page is informational and not investment advice.